Our results showed that treatment of aggressive melanoma cells with just 15 μM DAPT could increase PS-1 levels and decrease Wnt signaling and cell migration, suggesting that metastatic potential in melanoma could be reduced by increasing PS-1 expression. This evidence concerns the gene PSEN1 and melanoma.